Apr 28, 2024, 05:14
Aleix Prat: Our new article about attitudes towards HER2DX in Spain
Aleix Prat, Director of the Cancer Institute at Hospital Clinic of Barcelona, shared on X/Twitter:
“Our new article is out, led by Olga Martínez-Sáez! Management of early-stage HER2+ breast cancer and attitudes towards HER2DX in Spain.
An online questionnaire was conducted by an independent third-party across 70 medical oncologists highly specialized in breast cancer in Spain. Conclusions:
- A notable diversity in therapeutic approaches was observed in the same clinical scenario
- The majority acknowledged HER2DX as a clinically valuable test for specific patients”
Further reading.
Source: Aleix Prat/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54